Recognition of drug resistance during remission induction therapy for acute non-lymphocytic leukemia: Utility of day 6 bone marrow biopsy
- 1 January 1983
- journal article
- research article
- Published by Elsevier in Leukemia Research
- Vol. 7 (1) , 67-75
- https://doi.org/10.1016/0145-2126(83)90059-0
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Remission induction in acute nonlymphocytic leukemia: Comparison of a seven‐day and ten‐day infusion of cytosine arabinoside in combination with adriamycinMedical and Pediatric Oncology, 1979
- Failure of remission induction in acute myelocytic leukemiaMedical and Pediatric Oncology, 1978
- Treatment of acute myeloid leukaemia with a triple cytotoxic regime: datBritish Journal of Cancer, 1977
- ADRIAMYCIN-CYTOSINE ARABINOSIDE THERAPY FOR ADULT ACUTE MYELOCYTIC-LEUKEMIA1977
- Acute myelocytic leukemiaArchives of internal medicine (1960), 1976
- Progress in the treatment of adults with acute leukemia: review of regimens containing cytarabine studied by the Southwest Oncology GroupArchives of internal medicine (1960), 1976
- RANDOMIZED CLINICAL COMPARISON OF DAUNORUBICIN (NSC-82151) ALONE WITH A COMBINATION OF DAUNORUBICIN, CYTOSINE-ARABINOSIDE (NSC-63878), 6-THIOGUANINE (NSC-752), AND PYRIMETHAMINE (NSC-3061) FOR TREATMENT OF ACUTE NONLYMPHOCYTIC LEUKEMIA1976
- Comparative study of cytosine arabinoside therapy alone and combined with thioguanine, mercaptopurine, or daunorubicin in acute myelocytic leukemiaCancer, 1975
- Treatment of acute leukemia in adultsCancer, 1975